1E Therapeutics
Drug development company creating first-in-class RNA-targeting therapeutics using a proprietary platform.
About
Technology stack
detected 2026-06-18No comments yet. Be the first to share your take.
What does 1E Therapeutics do?
1E Therapeutics is a drug development company creating a novel class of programmable oligonucleotide therapeutics designed to treat intractable diseases by autonomously and precisely silencing disease-causing RNAs. Their patented platform enables the creation of safer, more targeted therapies for genetically driven diseases, infectious diseases, and chronic conditions.
How much funding has 1E Therapeutics raised?
1E Therapeutics has raised a total of $120M in funding. The most recent round on record is Seed.
When was 1E Therapeutics founded?
1E Therapeutics was founded in 2020.
What industry does 1E Therapeutics operate in?
1E Therapeutics operates in Drug Development, Life Sciences, Therapeutics, RNA-Targeting, Biotech, Drug Discovery.
How many employees does 1E Therapeutics have?
1E Therapeutics has approximately 47 people on record.